RSCM
Rock Springs Capital Management’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.2M | Sell |
51,030
-9,220
| -15% | -$2.02M | 0.7% | 50 |
|
2025
Q1 | $13.5M | Sell |
60,250
-108,500
| -64% | -$24.3M | 0.77% | 46 |
|
2024
Q4 | $55.3M | Buy |
168,750
+1,000
| +0.6% | +$328K | 2.1% | 14 |
|
2024
Q3 | $50.4M | Buy |
167,750
+22,250
| +15% | +$6.68M | 1.64% | 20 |
|
2024
Q2 | $47.9M | Buy |
145,500
+8,250
| +6% | +$2.72M | 1.44% | 26 |
|
2024
Q1 | $54.3M | Hold |
137,250
| – | – | 1.38% | 25 |
|
2023
Q4 | $48.3M | Sell |
137,250
-64,750
| -32% | -$22.8M | 1.19% | 28 |
|
2023
Q3 | $75.8M | Hold |
202,000
| – | – | 2.03% | 14 |
|
2023
Q2 | $77.3M | Hold |
202,000
| – | – | 1.84% | 16 |
|
2023
Q1 | $70M | Buy |
202,000
+16,500
| +9% | +$5.72M | 1.67% | 19 |
|
2022
Q4 | $43.7M | Buy |
185,500
+5,000
| +3% | +$1.18M | 1.05% | 36 |
|
2022
Q3 | $44.4M | Buy |
180,500
+69,500
| +63% | +$17.1M | 1.15% | 28 |
|
2022
Q2 | $33.6M | Buy |
111,000
+41,750
| +60% | +$12.6M | 0.98% | 35 |
|
2022
Q1 | $28.4M | Buy |
69,250
+23,750
| +52% | +$9.75M | 0.72% | 46 |
|
2021
Q4 | $21.3M | Buy |
45,500
+15,500
| +52% | +$7.27M | 0.49% | 63 |
|
2021
Q3 | $12.7M | Buy |
30,000
+1,500
| +5% | +$637K | 0.27% | 95 |
|
2021
Q2 | $10.2M | Hold |
28,500
| – | – | 0.2% | 112 |
|
2021
Q1 | $8.03M | Hold |
28,500
| – | – | 0.18% | 123 |
|
2020
Q4 | $8.07M | Hold |
28,500
| – | – | 0.17% | 120 |
|
2020
Q3 | $7.84M | Sell |
28,500
-42,500
| -60% | -$11.7M | 0.2% | 112 |
|
2020
Q2 | $16.1M | Hold |
71,000
| – | – | 0.44% | 76 |
|
2020
Q1 | $10.8M | Sell |
71,000
-81,500
| -53% | -$12.4M | 0.45% | 72 |
|
2019
Q4 | $22.9M | Hold |
152,500
| – | – | 0.72% | 53 |
|
2019
Q3 | $21.6M | Buy |
152,500
+15,000
| +11% | +$2.13M | 0.86% | 42 |
|
2019
Q2 | $17.2M | Buy |
137,500
+12,500
| +10% | +$1.56M | 0.62% | 57 |
|
2019
Q1 | $13.8M | Sell |
125,000
-35,000
| -22% | -$3.86M | 0.53% | 62 |
|
2018
Q4 | $15.7M | Hold |
160,000
| – | – | 0.74% | 40 |
|
2018
Q3 | $19.8M | Hold |
160,000
| – | – | 0.72% | 48 |
|
2018
Q2 | $15.9M | Buy |
+160,000
| New | +$15.9M | 0.61% | 60 |
|